CSL Seqirus Expands U.S. Availability Of Influenza Vaccine
Sept 29 (Reuters) - CSL Seqirus:
CSL SEQIRUS EXPANDS U.S. AVAILABILITY OF INFLUENZA VACCINE FOLLOWING SUCCESSFUL COMPLETION OF THE 2026/27 MANUFACTURING CAMPAIGN
Further company coverage: CSL.AX